BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36691723)

  • 1. Concomitant latent pulmonary vascular disease leads to impaired global cardiac performance in heart failure with preserved ejection fraction.
    Schuster A; Schulz A; Lange T; Evertz R; Hartmann F; Kowallick JT; Hellenkamp K; Uecker M; Seidler T; Hasenfuß G; Backhaus SJ
    Eur J Heart Fail; 2023 Mar; 25(3):322-331. PubMed ID: 36691723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
    Borlaug BA; Blair J; Bergmann MW; Bugger H; Burkhoff D; Bruch L; Celermajer DS; Claggett B; Cleland JGF; Cutlip DE; Dauber I; Eicher JC; Gao Q; Gorter TM; Gustafsson F; Hayward C; van der Heyden J; Hasenfuß G; Hummel SL; Kaye DM; Komtebedde J; Massaro JM; Mazurek JA; McKenzie S; Mehta SR; Petrie MC; Post MC; Nair A; Rieth A; Silvestry FE; Solomon SD; Trochu JN; Van Veldhuisen DJ; Westenfeld R; Leon MB; Shah SJ;
    Circulation; 2022 May; 145(21):1592-1604. PubMed ID: 35354306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance rest and exercise-stress left atrioventricular coupling index to detect diastolic dysfunction.
    Backhaus SJ; Lange T; Schulz A; Evertz R; Frey SM; Hasenfuß G; Schuster A
    Am J Physiol Heart Circ Physiol; 2023 May; 324(5):H686-H695. PubMed ID: 36897745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise Stress Real-Time Cardiac Magnetic Resonance Imaging for Noninvasive Characterization of Heart Failure With Preserved Ejection Fraction: The HFpEF-Stress Trial.
    Backhaus SJ; Lange T; George EF; Hellenkamp K; Gertz RJ; Billing M; Wachter R; Steinmetz M; Kutty S; Raaz U; Lotz J; Friede T; Uecker M; Hasenfuß G; Seidler T; Schuster A
    Circulation; 2021 Apr; 143(15):1484-1498. PubMed ID: 33472397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction.
    Borlaug BA; Kane GC; Melenovsky V; Olson TP
    Eur Heart J; 2016 Nov; 37(43):3293-3302. PubMed ID: 27354047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial.
    Patel RB; Silvestry FE; Komtebedde J; Solomon SD; Hasenfuß G; Litwin SE; Borlaug BA; Price MJ; Kawash R; Hummel SL; Cutlip DE; Leon MB; van Veldhuisen DJ; Rieth AJ; McKenzie S; Bugger H; Mazurek JA; Kapadia SR; Vanderheyden M; Ky B; Shah SJ
    JAMA Cardiol; 2024 Jun; 9(6):507-522. PubMed ID: 38630494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.
    Gorter TM; Obokata M; Reddy YNV; Melenovsky V; Borlaug BA
    Eur Heart J; 2018 Aug; 39(30):2825-2835. PubMed ID: 29947750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rest and exercise-stress estimated pulmonary capillary wedge pressure using real-time free-breathing cardiovascular magnetic resonance imaging.
    Backhaus SJ; Schulz A; Lange T; Evertz R; Kowallick JT; Hasenfuß G; Schuster A
    J Cardiovasc Magn Reson; 2024 Summer; 26(1):101032. PubMed ID: 38431079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Related Differences in Dynamic Right Ventricular-Pulmonary Vascular Coupling in Heart Failure With Preserved Ejection Fraction.
    Singh I; Oliveira RKF; Heerdt PM; Pari R; Systrom DM; Waxman AB
    Chest; 2021 Jun; 159(6):2402-2416. PubMed ID: 33388286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-exercise left atrial conduit strain predicted hemodynamic change in heart failure with preserved ejection fraction.
    Cheng JF; Huang PS; Chen ZW; Huang CY; Lan CW; Chen SY; Lin LY; Wu CK
    Eur Radiol; 2024 Mar; 34(3):1825-1835. PubMed ID: 37650970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of left ventricular diastolic function profile in patients with pulmonary hypertension due to heart failure with preserved ejection fraction.
    Raeisi-Giglou P; Lam L; Tamarappoo BK; Newman J; Dweik RA; Tonelli AR
    Clin Cardiol; 2017 Jun; 40(6):356-363. PubMed ID: 28026030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure-Volume Loops.
    Rommel KP; von Roeder M; Oberueck C; Latuscynski K; Besler C; Blazek S; Stiermaier T; Fengler K; Adams V; Sandri M; Linke A; Schuler G; Thiele H; Lurz P
    Circ Heart Fail; 2018 Feb; 11(2):e004121. PubMed ID: 29449367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trial.
    Backhaus SJ; Uzun H; Rösel SF; Schulz A; Lange T; Crawley RJ; Evertz R; Hasenfuß G; Schuster A
    EBioMedicine; 2022 Dec; 86():104334. PubMed ID: 36423376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right ventricular and cyclic guanosine monophosphate signalling abnormalities in stages B and C of heart failure with preserved ejection fraction.
    Petit T; Claessen G; Claeys M; La Gerche A; Claus P; Ghysels S; Delcroix M; Ciarka A; Droogne W; Van Cleemput J; Willems R; Voigt JU; Bogaert J; Janssens S
    ESC Heart Fail; 2021 Dec; 8(6):4661-4673. PubMed ID: 34477327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular deformation at rest predicts exercise-induced elevation in pulmonary artery wedge pressure in patients with unexplained dyspnoea.
    Biering-Sørensen T; Santos M; Rivero J; McCullough SD; West E; Opotowsky AR; Waxman AB; Systrom DM; Shah AM
    Eur J Heart Fail; 2017 Jan; 19(1):101-110. PubMed ID: 27878925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right atrial-right ventricular coupling in heart failure with preserved ejection fraction.
    von Roeder M; Kowallick JT; Rommel KP; Blazek S; Besler C; Fengler K; Lotz J; Hasenfuß G; Lücke C; Gutberlet M; Thiele H; Schuster A; Lurz P
    Clin Res Cardiol; 2020 Jan; 109(1):54-66. PubMed ID: 31053957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.
    Burke MA; Katz DH; Beussink L; Selvaraj S; Gupta DK; Fox J; Chakrabarti S; Sauer AJ; Rich JD; Freed BH; Shah SJ
    Circ Heart Fail; 2014 Mar; 7(2):288-99. PubMed ID: 24365774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right Ventricular-Vascular Uncoupling Predicts Pulmonary Hypertension in Clinically Diagnosed Heart Failure With Preserved Ejection Fraction.
    Chen ZW; Chung YW; Cheng JF; Huang CY; Chen SY; Lin LY; Lai HC; Wu CK
    J Am Heart Assoc; 2024 Jan; 13(1):e030025. PubMed ID: 38156457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.
    Kaye DM; Petrie MC; McKenzie S; Hasenfuβ G; Malek F; Post M; Doughty RN; Trochu JN; Gustafsson F; Lang I; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Hausleiter J; Raake P; Jondeau G; Bergmann MW; Spelman T; Aytug H; Ponikowski P; Hayward C;
    ESC Heart Fail; 2019 Feb; 6(1):62-69. PubMed ID: 30311437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.